Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Gliadel successfully completes mutual recognition procedure in 10 E.U. countries

June 25, 1999

Bristol-Myers Squibb files for FDA approval of Taxol/Herceptin combination

June 25, 1999

GlycoDesign expands GD0039 phase II cancer trial to additional site

June 24, 1999

Does melatonin improve the tolerability of chemotherapy?

June 24, 1999

Cell Pathways completes phase III APC trial analysis

June 24, 1999

U.K. is first market for new formulation of Casodex

June 23, 1999

Anti-VEGF antibody reverses ascites associated with ovarian cancer in rodent model

June 22, 1999

Sustained-release formulation of GnRH antagonist assessed for PD/PK in dogs

June 21, 1999

Lead GnRH antagonist presented at Endocrine Society meeting by Abbott, TAP

June 21, 1999

New paclitaxel derivatives with broad anticancer activity developed at Xechem

June 21, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...